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ABSTRACT 
The two human colon carcinoma cell lines HT-29 and SW620, which stably express herpes simplex virus 
thymidine kinase (HSV-TK), are sensitized to the cytotoxic effects of the antiviral drug ganciclovir (GCV), 
Compared with HT-29 cells, S W 6 2 0 cells were more sensitive to lower G C V concentrations (<1 fiM), accu 
mulated G C V triphosphate more rapidly, and incorporated higher levels of G C V into D N A . Following a 24 
hr exposure to 10 fiM G C V , bystander killing was as much as sixfold greater in S W 6 2 0 cells than HT-29 cells, 
This bystander effect was dependent on the level of H S V - T K expression, the number of cells expressing H S V 
T K , and the overall confluency of the cells. However, bystander killing did not correlate with gap junctional 
intercellular communication as determined by microinjection of Lucifer Yellow fluorescent dye. S W 6 2 0 cells 
were coupled to < 3 % adjacent cells (compared with > 5 0 % for HT-29 cells), but were still able to transfer 
phosphorylated G C V to bystander cells as soon as 4 hr after drug was added. These results emphasize the 
importance of cell-specific metabolism in HSV-TK/GCV-mediated cytotoxicity and m a y suggest a novel mech-
anism for bystander killing. 
OVERVIEW SUMMARY 
The transfer of HSV-TK into tumor cells and the subse-
quent sensitization to G C V have resulted in successful an-
titumor effects both in vitro and in vivo for a variety of can-
cers. This study focuses on evaluating and comparing two 
colon carcinoma cell lines for their ability to metabolize 
G C V and transfer phosphorylated metabolites to neigh-
boring non-HSV-TK-expressing cells (bystander effect). 
Here we demonstrate differences in HSV-TK expression, 
G C V triphosphate accumulation, and incorporation into 
D N A and their effect on cytotoxicity. W e also provide evi-
dence of the transfer of phosphorylated G C V to bystander 
cells in a cell line deficient in gap junctional intercellular 
communication. 
INTRODUCTION 
^HE MAJOR IMPETUS for the development of enzyme-prodmg 
strategies for cancer therapy is the prospect of selectively 
sensitizing tumor cells to a drug that is nontoxic to normal cells. 
Several different approaches have been reported in which a vi-
ral or bacterial enzyme (encoded by a suicide gene) is intro-
duced into cancer cells and allows them to activate normally 
innocuous compounds to cytotoxic forms (Mullen et al, 1992; 
Moolten, 1994; Bridgewater et al, 1995). One such strategy in-
volves transfer of the cDNA for the herpes simplex virus thymi-
dine kinase (HSV-TK) gene into tumor cells; the gene then sen-
sitizes the cells to the antiviral dmg ganciclovir (GCV) 
(Moolten, 1986). Tumor cells expressing this viral kinase are 
able to phosphorylate ganciclovir to its cytotoxic metabolite. At 
first glance, this strategy would appear to be limited by the num-
ber of cells that can be transduced, since phosphorylated gan-
ciclovir is unable to diffuse freely across the plasma membrane. 
However, this form of therapy is made more effective by a phe-
nomenon termed the bystander effect. The bystander effect de-
scribes the ability of a small percentage of HSV-TK-express-
ing cells to sensitize non-HSV-TK-expressing cells to GCV, 
and is responsible for the eradication of a tumor when only a 
fraction of the cells are transduced with HSV-TK (Moolten, 
1986; Freeman et al, 1993; DiMaio et al, 1994). This form of 
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treatinent has been successful in vitro witii many different types 
of tumor cells and resulted in marked tumor regression in sev-
eral animal models (Ezzeddine era/., 1991; Camso era/., 1993; 
R a m et al, 1993; Vile and Hart, 1993; DiMaio et al, 1994; Ido 
et al, 1995; O'Malley et al, 1995; Yoshida et al, 1995). It is 
because of these promising results that approved protocols for 
clinical tiials involving this form of gene therapy have been ini-
tiated for flie treatment of brain and ovarian tumors (reviewed 
in Roth and Cristiano, 1997). 
While HSV-TK/ganciclovir gene therapy has proven to be 
an effective strategy for treating some cancers in animal mod-
els, relatively littie is understood about the basic mechanism of 
ganciclovir cytotoxicity and the bystander effect in tumor cells. 
Most of the information regarding the mechanism of ganciclovir 
comes from the analysis of its antiviral activity in the treatment 
of herpes simplex vims and cytomegalovims infection (Field et 
al, 1983; Martin et al, 1983; Biron et al, 1985; Faulds and 
Heel, 1990). While these studies are informative, they may not 
represent the cytotoxic mechanisms occurring in HSV-TK-ex-
pressing and nonexpressing mammalian cells. In HSV-TK-ex-
pressing cells, ganciclovir is preferentially phosphorylated to 
its triphosphate derivative, which then competes with endoge-
nous d G T P pools for incorporation into D N A (Balzarini et al, 
1993). The presence of two hydroxyl groups on the acyclic moi-
ety allows incorporation of G C V monophosphate internally into 
nascent D N A (St. Clair et al, 1987). Ganciclovir triphosphate 
is a potent inhibitor of viral D N A polymerase and viral D N A 
synthesis and, compared with other related nucleotide analogs, 
is a selective inhibitor of mammalian 5 polymerase (Smee et 
al, 1985; St. Clair ef al, 1987; Ilsley et al, 1995). Previous 
studies performed in our laboratory and using rat glioblastoma 
cells established that ganciclovir displays unique properties 
when compared with other, stmcturally related nucleoside 
analogs such as acyclovir and arabinofuranosylthymine (araT) 
(Shewach et al, 1994b). Of these dmgs, only ganciclovir 
elicited a 4- to 5-log cell kill (Shewach et al, 1994b). Since 
such a powerful cytotoxic agent could have a major impact on 
the treatment of cancer, understanding and characterizing its 
metabolism in human tumor cells will be important for opti-
mizing its therapeutic efficacy. 
Equally important in understanding the mechanism of G C V 
cytotoxicity in HSV-TK-expressing cells is the bystander ef-
fect, which mediates cytotoxicity in neighboring cells that lack 
HSV-TK. Several theories have been proposed to explain the 
observed bystander killing in vitro or in vivo. They include (1) 
transfer of phosphorylated G C V via gap junctional intercellu-
lar communication (GJIC), (2) phagocytosis by non-HSV-TK-
expressing cells of apoptotic vesicles containing G C V metabo-
lites from HSV-TK-expressing tumor cells, (3) destmction of 
tumor vasculature, and (4) induction of an immune response 
against the tumor (Bi et al, 1993; R a m et al, 1993; Freeman 
et al, 1993, 1995; Samejima and Memelo, 1995; Ramesh et 
al, 1996). Since current methodologies for transducing genes 
in vivo allow only a small proportion of the tumor to actually 
express HSV-TK, bystander killing is critical for the success-
ful eradication of tumors. Elucidating these mechanisms may 
offer new strategies for improving the clinical application of 
HSV - T K / G C V gene therapy. 
Although there are numerous reports of the antitumor effect 
of ganciclovir, none has examined the metabolism of G C V in 
relationship to its cytotoxicity. Outside of isolated reports on 
the transport and phosphorylation of G C V , reports of the phar-
macodynamics of G C V in uninfected tumor cells are largely 
lacking (Mahony etal, 1991; Agbaria etal, 1994; Ishii-Morita 
et al, 1997). Therefore, we have undertaken a detailed study 
of the metabolism of G C V in tumor cell lines. 
Suicide gene therapy has been proposed as a novel treatment 
for colon cancer metastatic to the liver (Huber era/., 1991,1993; 
Camso er al, 1993; Hirschowitz et al, 1995). Here we have 
evaluated two colorectal carcinoma cell lines for their sensitiv-
ity to G C V . Adenoviral transduction of H S V - T K rendered these 
cell lines sensitive to G C V with bystander killing. W e have sub-
sequently developed clonal sublines that stably express HSV-
TK. While all clones were sensitive to G C V , clones derived 
from the same cell type exhibited as much as a 10-fold differ-
ence in cytotoxicity. The availability of these stably transduced 
cell lines, which vary in their response to ganciclovir, allowed 
us to examine the underiying parameters conferring sensitivity 
to ganciclovir. In addition, HT-29 and S W 6 2 0 cells differ in 
their capacities for GJIC and, therefore, allowed us to investi-
gate the importance of this function in bystander killing. 
MATERIALS AND METHODS 
Cell culture and generation of stable cell lines 
The human colon carcinoma cell lines HT-29 and S W 6 2 0 
were cultured in McCoy's 5 A medium supplemented with l-
glutamine and 1 0 % fetal bovine s e m m (GIBCO-BRL, Grand 
Island, N Y ) . Cells were maintained in exponential growth in a 
humidified incubator at 37°C in atmosphere of 5 % C O 2 and 
9 5 % air. 
HT-29 and S W 6 2 0 clonal cell lines, which stably expressed 
HSV-TK, were developed from their parental cell line by use 
of a retrovirus vector containing the c D N A for H S V - T K under 
control of the 5' long terminal repeat sequence and the amino-
glycoside phosphotransferase gene for selection with the 
neomycin analog G418 (a generous gift from B. Davidson, Uni-
versity of Iowa, Iowa City, lA). Amphotropic retroviral pro-
ducer cells (PAT 2.4 NIH 3T3; from B. Davidson) were grown 
to approximately 7 0 % confluency, at which time the super-
natant was harvested, filtered, and pipetted onto HT-29 and 
S W 6 2 0 cultures in the presence of 8 /xM Polybrene. The vims-
containing medium was removed and replaced with fresh 
medium 24 hr later. After 2 days of culture, the cells were pas-
saged and grown in culture medium containing G418 (800 
fj.g/m\) for approximately 2 weeks. Those cells surviving se-
lection were diluted to produce monoclonal colonies. Ten 
clones were derived from each cell line and maintained in G418 
(400 /Ag/ml). HT-29 and S W 6 2 0 clonal cell lines stably ex-
pressing ^-galactosidase were developed similarly using an 
AdRSVIacZ vector (a generous gift from J. Maybaum, Uni-
versity of Michigan, Ann Arbor, MI) and verified by a chro-
mogenic assay (see below). 
S W 6 2 0 cells expressing the pHook single-chain antibody 
were produced by stable ti-ansfection. Parental S W 6 2 0 cells 
were plated onto 60-mm-diameter culture dishes at a density of 
10^ cells/dish and grown ovemight. Cells were transfected with 
5 pg of pHook-2 vector (Invitrogen, Carlsbad, C A ) and 20 /xl 
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of Lipofectin in 2 ml of Opti-MEM I medium (GIBCO-BRL). 
Following a 24-hr incubation, the DNA-containing medium was 
removed and the cells were allowed to grow an additional 24 
hr. Cells were subcultured and grown 2 weeks in G418 (800 
/xg/ml)-containing selection medium. Surviving cells were sub-
jected to magnetic separation and dilution. Monoclonal popu-
lations were derived and maintained in G418 (400 /xg/ml). 
In vitro adenoviral transduction 
ConshTiction of adenovims vectors has been reported previ-
ously (Shewach etal, 1994b). Parental HT-29 and S W 6 2 0 cells 
were plated at a density of 0.5 X 10^ cells/25-cm2 flask and al-
lowed to grow for 48 hr. Culture medium was removed, the 
cells were rinsed twice in semm-free medium, and Ad.RSVtk 
was added at a multiplicity of infection (MOI) of either 10 or 
100 in 5 ml of serum-free McCoy's 5 A medium. Following a 
4-hr incubation, culture medium was supplemented with fetal 
bovine serum to a final concentration of 2 % and grown 
ovemight. Adenovims-containing medium was removed, and 
the cells were rinsed twice with medium containing 1 0 % semm 
and allowed to grow in complete medium for an additional 24 
hr before being subcultured for cytotoxicity assays. 
Cell survival assays 
Colony formation assays were utilized to test for the pres-
ence of H S V - T K and sensitivity to ganciclovir (Shewach et al, 
1994b). Culture flasks (25 cm^) were plated with 0.5 to 1 X 
10* HT-29 or S W 6 2 0 cells at least 24 hr before exposure to 
dmg. Exponentially growing cells were treated with 0.01 to 10 
p M ganciclovir (Cytovene; Syntex, Palo Alto, C A ) for 2 to 24 
hr. Cells were tryspinized, counted with a Coulter (Hialeah, FL) 
electronic particle counter, and diluted to approximately 100 vi-
able cells per 35-mm-diameter well in six-well culture dishes. 
After 10-14 days the resulting cell colonies were fixed in 
methanol-glacial acetic acid (3:1, v/v), stained with 0.4% crys-
tal violet, and visually counted. Cell survival was expressed as 
a fraction of plating efficiency for untreated cells. All colony 
formation assays were performed independently at least twice 
and each point was plated at least in triplicate. Data are reported 
as the mean ± standard error of the mean (Zar, 1974). 
X-Gal staining of ^-galactosidase-expressing cells 
In experiments in which bystander cell survival was mea-
sured, a chromogenic assay was utilized to determine the num-
ber of surviving /3-galactosidase-expressing cells (Lim and 
Chae, 1989). Colony formation assays were performed as de-
scribed above, except that surviving colonies were fixed for 15 
min in 2 % glutaraldehyde, washed with phosphate-buffered 
saline (PBS), and stained witii 0.2% 5-bromo-4-chloro-3-in-
dolyl-/8-D-galactoside (X-Gal; Boehringer Mannheim, Indi-
anapolis, IN). Blue-stained colonies were visually enumerated. 
Isolation of total RNA and Northern analysis 
Total RNA from HT-29 clones 4, 8, and LacZ and from 
S W 6 2 0 clones 2, 3, and LacZ was extracted from 7 0 % conflu-
ent cultures in 100-mm culture dishes using TRIzol reagent 
(GIBCO-BRL). A n equal amount of total R N A (20 /xg) was 
loaded onto a 1 % agarose gel and separated by electrophoresis. 
R N A was transferred to a Hybond-N-(- nylon membrane (Amer-
sham, Arlington Heights, IL) by capillary action ovemight in 
20X SSC (IX SSC is 0.15 M NaCl plus 0.015 M sodium cit-
rate). The membrane was cross-linked and prehybridized with 
5 X Denhardt solution, 5X SSC, 0.5% sodium dodecyl sulfate 
(SDS), and salmon sperm D N A (10 /xg/ml). The blot was then 
hybridized ovemight at 65°C with [y-^^pjjcjp.jajjjojabeled 
H S V - T K c D N A prepared using a random primer DNA-labeling 
system (GIBCO-BRL). The blot was washed three times with 
2 X SSC and 0.1% S D S at 65°C, subjected to autoradiography, 
and developed after exposure for 1-2 days at —70°C. 
Analyses of cellular GCV nucleotides 
Clonal cell lines were characterized for their ability to ac-
cumulate phosphorylated ganciclovir, using a nucleotide pool 
assay described previously (Shewach er al, 1994a). Briefly, 
cells were treated for 2 to 24 hr with 1 p M G C V containing 
— 1 0 % [S-'HJganciclovir (Moravek Biochemicals, Brea, C A ) , 
harvested by trypsinization, and counted. Cellular nucleotides 
were extracted with ice-cold 0.4 N perchloric acid. The phos-
phorylated derivatives of ganciclovir were separated from en-
dogenous nucleotides and quantitated by strong anion-exchange 
high-performance liquid chromatography (HPLC) using a W a -
ters (Milford, M A ) gradient system composed of two model 
501 pumps, a U 6 K injector module, and a model 996 photodi-
ode array detector; the system was controlled by Millenium 
2010 software. Before injection, each sample was spun at 
12,000 X g for 5 min to remove particulate matter and the p H 
was adjusted to p H 2.8 to match the starting elution buffer pH. 
Samples were loaded onto a 5-/xm Partisphere 4.6 X 250 m m 
S A X column (Whatman, Hillsboro, O R ) and nucleoside 
triphosphates were eluted with a linear gradient of ammonium 
phosphate buffer ranging from 0.15 M , p H 2.8, to 0.6 M , p H 
3.8. Ganciclovir triphosphate was resolved completely from the 
endogenous nucleotides by these procedures. Retention times 
for the nucleotide triphosphates were as follows: CTP/dCTP, 
20 min; UTP, 21.5 min; dTTP, 22.0 min; ATP, 26.0 min; dATP, 
28.3 min; G C V triphosphate, 29.8 min; GTP, 32.1 min; and 
dGTP, 33.0 min. Nucleotides were identified on the basis of 
their ultraviolet spectmm over the range of 200-355 n m and by 
coelution with authentic standards. Cellular nucleotides were 
quantitated by comparison of their peak areas with that of a 
known amount of the appropriate standard at wavelengths 254 
and 281. Fractions containing radiolabeled ganciclovir nu-
cleotides were collected and quantitated by liquid scintillation 
spectrometry on the basis of the known specific activity of the 
tritiated ganciclovir. 
The acid-insoluble cell pellets were washed with 0.4 N per-
chloric acid and solubilized ovemight in 1 A^ K O H . Incorpora-
tion of [^H]GCV into D N A was then estimated by quantitating 
the amount of radiolabeled G C V by liquid scintillation spec-
trometry. Isolation of cellular D N A and R N A fractions sepa-
rately demonstrated that S:97% of the tritium was associated 
with D N A , whereas R N A contained only background levels of 
tritium (data not shown). 
Separation of pHook-expressing cells 
Mixtures of SW620 cell lines expressing pHook and HSV-
T K were plated onto 35-mm-diameter six-well culture dishes 
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at a density of 0.5 to 1 X 10* cells/dish and grown ovemight. 
Following radiolabeled dmg treatment, cells were harvested 
with PBS-3 m M E D T A and pipeted to achieve a single-cell 
suspension. Cells were then rotated for 30 min in 1 ml of com-
plete medium in the presence of 3 X 10* magnetic beads coated 
with 4-ethoxymethylene-2-phenyl-2-oxazolin-5-one (phOx, 
Capture-Tec Beads; Invitrogen). pHook expressing cells pro-
duce an extracellular single-chain antibody directed toward 
phOx, allowing the physical separation of these cells with a 
magnet (Griffiths et al, 1984; Hoogenboom et al, 1991; 
Coloma et al, 1992). Tubes containing the cells were placed 
in a magnetic stand and mixed for 2 min. Cells not bound to 
magnetic beads were removed. The bound cells were exten-
sively washed, resuspended in 1 ml of complete medium, and 
counted before being subjected to nucleotide pool analysis. 
RESULTS 
Sensitization of colon carcinoma cells following 
adenoviral transfer of H S V - T K 
To determine the feasibility of HSV-TK/ganciclovir gene 
therapy for colorectal carcinoma, primary (HT-29) and metasta-
tic (SW620) human adenocarcinoma cell lines were transduced 
with an adenovims vector containing the HSV-TK gene. Both 
cell lines were rendered sensitive to ganciclovir at M O I of 10 
and 100 (Fig. 1). Cytotoxicity was dose dependent and in-
creased with increasing MOIs in both cell lines. SW620 cells 
were more sensitive to lower concentrations of ganciclovir, with 
an IC50 (50% cytotoxic concentration) of 0.06 /xM compared 
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FIG. 1. Cytotoxicity after adenoviral transduction in HT-29 
(squares) and S W 6 2 0 (circles) colon carcinoma cells. Cells 
were transduced with Ad.RSVtic at MOIs of 10 (open symbols) 
or 100 (closed symbols). Cell survival was determined by 
colony formation assay following a 24-hr exposure to increas-
ing concentrations of G C V . Cells transduced with Ad.RSVlacZ 
served as a control (diamonds). Values represent the mean ± 
S E M of triplicate samples from two separate experiments. 
ganciclovir concentration (10 p M ) achieved an approximately 
1-log greater cell kill than did S W 6 2 0 cells. In parallel exper-
iments using an adenovims vector containing the lacZ gene in 
place of HSV-TK, the level of transduction for both cell lines 
was estimated to be 0.5 and 5 % for MOIs of 10 and 100, re-
spectively (data not shown). Although this may underestimate 
the number of cells expressing HSV-TK, these experiments at 
an M O I of 10 suggests that some bystander killing of non-
transduced cells occurred. 
Development and sensitivity of stable 
HSV-TK-expressing HT-29 and S W 6 2 0 clones 
To study the role of HSV-TK expression and/or metabolism 
in the cytotoxicity of ganciclovir, clonal cell populations of both 
HT-29 and S W 6 2 0 cell lines that stably express H S V - T K were 
developed using a retrovims vector containing the c D N A for 
H S V - T K and a neomycin resistance gene. Ten G418-resistant 
monoclonal sublines from each parental cell type were assayed 
for the presence of H S V - T K and sensitivity to ganciclovu". The 
range of cytotoxicity represented by four clones from each cell 
line is shown in Fig. 2. A > 10-fold difference in cell kill was 
observed between clones derived from each parental cell line. 
In addition, a more than 2-log difference in the sensitivity of 
individual clones was observed between cell lines. In all cases 
and consistent with the adenovims experiments, S W 6 2 0 cells 
expressing H S V - T K were more sensitive to low concentrations 
of ganciclovir compared with HT-29 cells. In each cell line, the 
clones exhibiting the largest difference in sensitivity to G C V 
were chosen for further characterization. HT-29 clone 4 and 
SW620 clone 2 exhibited both lower H S V - T K expression and 
activity compared with HT-29 clone 8 and S W 6 2 0 clone 3, re-
spectively. Growth rates of individual clones were similar with 
doubling times of 20 hr (clone 2), 23 hr (clones 3 and 4), and 
24 hr (clone 8). Increased sensitivity to G C V correlated with 
the higher H S V - T K expression as determined by Northem 
analysis (Fig. 3) and H S V - T K activity measured in cell lysates 
(data not shown; and Shewach etal, 1994b). These stably trans-
duced clonal cell lines vary in their response to ganciclovir, en-
abling a comparison between cytotoxicity and the effects of 
HSV-TK expression and ganciclovir metabolism. 
Measurement of GCV nucleotides in 
HSV-TK-expressing cells 
Since GCV triphosphate is the presumed cytotoxic metabo-
lite of ganciclovir, clonal cell lines were first characterized for 
their ability to phosphorylate G C V . In all cell lines expressing 
HSV-TK, ganciclovir was preferentially phosphorylated to its 
triphosphate derivative. Ganciclovir triphosphate accounted for 
the majority (70-80%) of the total radioactivity measured in 
cell lysates, with G C V mono- and diphosphate levels approxi-
mately 5 and 20% , respectively. As shown in Fig. 4, HT-29 and 
SW620 cells differed in their ability to accumulate G C V 
triphosphate during a 24-hr exposure to 1 /xM ganciclovir. Com-
pared with HT-29 cells, S W 6 2 0 cells displayed a more rapid 
accumulation of G C V h-iphosphate during the initial 8-hr ex-
posure to dmg. Accumulation of G C V triphosphate appeared 
to plateau after 8 hr for S W 6 2 0 clones and after 12 hr for HT-
29 clones. A twofold difference in G C V triphosphate accumu-
lation was observed between low and high HSV-TK-express-

















FIG. 2. GCV sensitivity of clonal HT-29 (A) and SW620 (B) 
cell lines stably expressing HSV-TK. Four (from a total of 10) 
monoclonal populations representing the range of G C V sensi-
tivity are shown here. Cells were selected after transduction 
with a retrovirus containing the c D N A for HSV-TK. Clono-
genic cell survival was determined after a 24-hr incubation with 
G C V . HT-29 clones 4 (open squares) and 8 (solid squares) and 
SW620 clones 2 (open circles) and 3 (solid circles) were cho-
sen for subsequent study because they represent the low and 
high extremes of G C V cytotoxicity. Triangles indicate clones 
with intermediate sensitivies to G C V . Control cells (diamonds) 
are a stable cell line expressing j8-galactosidase instead of HSV-
TK. Data are reported as the mean ± S E M (n a 3). 
ing clones from the same cell line after the first 4 hr of dmg 
exposure. This 2-fold difference in the level of G C V diphos-
phate corresponded to a 10-fold difference in cell death (Fig. 
2). However, somewhat higher G C V triphosphate levels were 
observed in HT-29 clone 8 compared with the two more sen-
sitive SW620 clones. After 12 hr of dmg exposure, these cell 
lines also differed in their ability to retain G C V triphosphate. 
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FIG. 3. Northem blot analysis of HSV-TK m R N A levels in 
HT-29 and SW620 monoclonal populations stably expressing 
HSV-TK. Twenty micrograms of total R N A from each clone 
was separated on a 1% agarose gel, transferred to a nylon mem-
brane, and hybridized to a ̂ ^P-radiolabeled HSV-TK c D N A 
probe. Northem blot autoradiograms of the more (HT-29 clone 
8 and SW6290 clone 3) and less (HT-29 clone 4 and SW620 
clone 2) GCV-sensitive clones are presented. Lanes indicated 
with a C represent total R N A from monoclones stably ex-
pressing LacZ. An equal amount of total R N A was loaded per 
well, on the basis of a comparison of 28S and 18S ribosomal 
R N A bands stained with ethidium bromide (data not shown). 
In Fig. 5, the initial half-life of G C V triphosphate was deter-
mined to be 5.5 and 3.5 hr for HT-29 and SW620 cell lines, re-
spectively. Half-lives for high- and low-expressing HSV-TK 
clones were similar. These results demonstrate that between the 
two clones of each subline, G C V sensitivity corresponded with 
higher accumulation of G C V triphosphate, while retention, 
based on the intracellular half-life of G C V triphosphate, was 
relatively short and similar between clones. 
Measurement of the level of GCV monophosphate 
incorporation in D N A 
Since incorporation of GCV monophosphate in DNA is 
thought to be important for cytotoxicity, the level of D N A in-
corporation was measured in the HSV-TK-expressing cell lines. 
In S W 6 2 0 cells, radiolabeled G C V in nucleic acid was associ-
ated exclusively with D N A (data not shown). The amount of 
G C V monophosphate incorporated in D N A in both HT-29 and 
S W 6 2 0 cells was measured and compared in Fig. 6. G C V 
monophosphate incorporation increased continuously over the 
24-hr incubation with 1 /xM G C V in all cell lines and repre-
sented approximately 2 to 8 % of the G C V triphosphate pools 
(Fig. 4). Again, a less than 2-fold difference between high 
(clones 8 and 3) and low (clones 4 and 2) HSV-TK-expressing 
clones corresponded to a 10-fold difference in cell survival. In 
addition, the amount of G C V monophosphate in D N A corre-
sponded to the relative sensitivity of the four cell lines. A s il-
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FIG. 4. Accumulation of [^H]GCV triphosphate in HT-29 (squares) and S W 6 2 0 (circles) low (open symbols) and high (solid 
symbols) HSV-TK-expressing clones. Exponentially growing cells were harvested at the indicated time points following the ad-
dition of 1 /xM G C V (containing approximately 1 0 % [^H]GCV) and nucleotides were analyzed by HP L C . Results are the aver-
age ± S E M from two experiments. 
lustrated in Fig. 7, the level of G C V monophosphate in D N A 
continued to increase even after removal of exogenous d m g and 
plateaued after 8 to 12 hr. These data suggest that, following 
incorporation into the D N A , G C V monophosphate is resistant 
to excision. 
Analysis of bystander killing in HT-29 and 
S W 6 2 0 cells 
Significant bystander cytotoxicity was indicated for both HT-
29 and S W 6 2 0 cells on the basis of the multilog kill observed 
with low levels of adenoviral transduction. Bystander killing 
was investigated further in experiments in which stably ex-
pressing H S V - T K cells were mixed with cells stably express-
ing LacZ. Following a 24-hr exposure to G C V , the survival of 
LacZ-expressing bystander cells was measured using a chro-
mogenic assay. Bystander cell killing was compared using ei-
ther two different ratios of HSV-TK- versus LacZ-expressing 
cells or two different cell densities (Fig. 8). In all cases tested, 
S W 6 2 0 cells (Fig. 8B) displayed greater bystander killing than 
HT-29 cells (Fig. 8A). The growth rates of HSV-TK- and LacZ-
expressing clones were similar, and the proportion of H S V - T K 
relative to LacZ cells (determined by X-Gal staining) at the con-
clusion of the d m g incubation period was similar to that in the 
initial culture setup. Bystander killing increased with higher 
H S V - T K expression and greater number of HSV-TK-express-
ing cells in both cell lines. The level of confluency also ap-
peared to be an important determinant of bystander killing since 
more S W 6 2 0 bystander cells were killed with 10 /xM G C V in 
mixtures of 2 5 % HSV-TK-expressing cells at high density com-
pared with low-density populations of 5 0 % H S V - T K expressers 
(Fig. 8B). To detennine whether bystander killing may be me-
diated by gap junctional intercellular communication (GJIC), 
the level of GJIC in both HT-29 and S W 6 2 0 cells was deter-
mined by the frequency of fluorescent dye tiansfer from indi-
vidual cells microinjected with Lucifer Yellow C H (Ren et al, 
1994). Microinjected, dye-loaded HT-29 cells were capable of 
transferring dye to more than 5 0 % of surrounding cells. In con-
trast, S W 6 2 0 cells transferred dye to fewer than 3 % of neigh-
boring cells. This demonstrates that as many as 9 5 % of the by-
stander S W 6 2 0 cells can be killed (Fig. 8B) even in the absence 
of significant GJIC. 
The extent of GCV triphosphate transfer between 
HSV-TK-expressing and bystander cells 
Since transfer of GCV nucleotides has been postulated as the 
mechanism for bystander cell killing with G C V , it was of in-
terest to determine whether this occurred in our system. Our 
initial approach to determine whether G C V triphosphate was 
transferred between HSV-TK-expressing cells and nonexpress-
ing bystander cells was to measure G C V nucleotide levels in 
mixed cultures containing equal numbers of each cell type. If 
no transfer occurred, then the amount of radiolabeled nu-
cleotides and D N A should be proportional to die amounts ob-
served in cultures of 100% H S V - T K cells. During a 24-hr ex-
posure to 1 p M G C V (Table 1), almost twice as much G C V 
triphosphate as expected was present for both cell lines and as 
much as three times the expected levels in the D N A . These data 
suggest but do not prove that G C V nucleotides are ti-ansferred 
from HSV-TK-expressing to nonexpressing cells. 
To determine conclusively whether G C V nucleotides are 
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FIG. 5. Retention of G C V triphosphate in HT-29 (squares) and S W 6 2 0 (circles) HSV-TK-expressing clones. Exponentially 
growing cells were incubated with 1 p M G C V (containing approximately 1 0 % [^H]GCV) for 4 hr (SW620) or 8 hr (HT-29), fol-
lowed by replacement of fresh growth medium (time, 0 hr). A longer incubation time was necessary for HT-29 cells to allow 
sufficient G C V triphosphate for detection in the absence of exogenous dmg. Eight-hour G C V triphosphate levels in HT-29 clones 
were more similar to G C V triphosphate accumulation after 4 hr in S W 6 2 0 clones (see Fig. 4). Nucleotides were extracted from 
cells and analyzed by H P L C . Data are from a single representative experiment. 
transferred to bystander cells, we developed an assay to phys-
ically separate HSV-TK- and non-HSV-TK-expressing cells. 
This separation allowed us to directly quantitate the levels of 
G C V nucleotides in each population individually. In these ex-
periments, bystander cells are represented by a monoclonal 
S W 6 2 0 cell line stably transfected with a pHook vector. pHook-
expressing cells produce a surface antibody that binds to hap-
ten-coated magnetic beads, enabling us to separate these (by-
stander) cells from cocultures using a magnetic apparatus. 
Cocultures consisting of 50:50 mixtures of HSV-TK- and 
pHook-expressing cells were subjected to separation using this 
pHook magnetic system. After extensive washing, the adherent 
cells accounted for 10-15% of the total cells. To verify the pu-
rity of this population, three control experiments were per-
formed. After separation, cells were plated and examined visu-
ally for the presence of magnetic beads. Ninety-nine percent of 
the isolated cells had at least one attached hapten bead. Cocul-
tures of 50:50 mixtures of pHook- and LacZ-expressing cells 
were grown, separated witii die magnetic apparatus, plated, and 
subjected to a chromogenic assay. The number of blue-stained 
cells were counted and the level of contaminating LacZ cells 
was determined to be approximately 3%. For the final control, 
we incubated 1 0 0 % HSV-TK-expressing cells (clone 3) with 1 
p M [^HJGCV for 24 hr. These cells were then harvested and 
mixed with an equal number of pHook cells and immediately 
separated with a magnet. [Radiolabeled G C V derivatives were 
not detected in the separated cells in which only background 
counts were observed compared with more than 1 X 10^ cpm 
of [^H]GCV triphosphate detected in the initial clone 3 cells.] 
These studies demonstrate that this technique was able to sep-
arate pHook-expressing from HSV-TK-expressing cells with 
> 9 7 % purity, and there was no artifactual carryover of ra-
dioactivity from the HSV-TK- to pHook-expressing cells. 
Table 2 shows the level of radiolabeled G C V triphosphate 
measured in bystander cells during a 24-hour incubation with 
1 /xM G C V . Beginning at 4 hr a significant transfer of phos-
phorylated G C V was observed. These data demonstrate that 
G C V triphosphate accumulated continuously in both bystander 
and HSV-TK-expressing cells throughout the incubation period, 
under both the low- and high-density conditions. Levels of G C V 
triphosphate in bystander cells increased with higher cell den-
sity, consistent with the greater toxicity to bystander cells at 
high density (Fig. 8B). Interestingly, the increase in G C V 
triphosphate with time in bystander cells grown at high density 
paralleled that in the HSV-TK/bystander cell mixtures, whereas 
smaller changes in G C V triphosphate were observed in by-
stander cells cultured at low density. These data demonstrate 
conclusively that G C V nucleotides can be transferred from 
HSV-TK-expressing to nonexpressing cells in cocultures, even 
in a cell line that exhibits low GJIC. 
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FIG. 6. Incorporation of [•'H]GCV monophosphate into D N A . The level of G C V monophosphate in D N A from HT-29 (squares) 
and SW620 (circles) low and high HSV-TK-expressing clones described in Fig. 4 was determined over a 24-hr time period fol-
lowing addition of 1 /xM G C V (containing approximately 1 0 % [^H]GCV). Nucleic acids were precipitated with perchloric acid 
and quantitated by liquid scintillation spectrometry. 
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FIG. 7. Incorporation of [^HIGCV monophosphate into D N A following removal of d m g HT-29 and S W 6 2 0 cells were treated 
with 1 /xM G C V (containing approximately 1 0 % [^HJGCV) for 8 and 4 hr, respectively, before d m g removal and samples were 
collected over a 24-hr time course. The amount of tntium in acid-insoluble nucleic acids from HT-29 (squares) and S W 6 2 0 (cir 
cles) low and high HSV-TK-expressing clones (Fig. 5) were quantitated by liquid scintillation specti-ometry. 
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FIG. 8. Effect of cell density and number of HSV-TK-expressing cells on the sensitivity of HT-29 (A) and S W 6 2 0 (B) clones. 
L o w HSV-TK-expressing clones are represented on the left, high expressers on the right. HSV-TK-expressing clones were co-
cultured with )3-galactosidase-expressing cells at either low (dashed lines, i ) or high densities (solid lines, f ) and at an H S V -
TK-to-LacZ clone ratio of 50:50 (solid symbols) or 25:75 (open symbols). Low-density cultures contained 2.5-3.5 X 10* cells/25-
cm^ flask for HT-29 cells and 4-5 X 10* cells/25-cm2 flask for S W 6 2 0 cells. High-density cultures contained 4.5-5.5 x 10* 
cells/25-cm2 flask and 8-9 X 10* cells/25-cm^ flask for HT-29 and S W 6 2 0 cells, respectively. Clonal cell survival of LacZ-ex-
pressing cells was determined by a chromogenic assay following a 24-hr incubation with G C V . Each point represents the mean ± 
S E M from at least six determinations. 
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Cocultures of HSV-TK-expressing and LacZ-expressing clones were incubated with 1 /xM G C V (containing 
approximately 10% [^HjGCV) for 24 hr. Cells were then harvested and the level of G C V triphosphate was 
measured by HPLC analysis. The amount of [^HjGCV monophosphate in D N A was measured in the acid-
insoluble cell extract. Data are from a representative experiment with cells treated at low density. The numbers in 
parentheses represent the percentage relative to cultures of 100% HSV-TK-expressing cells. 
DISCUSSION 
Many studies in the literature have demonstrated the excel-
lent antitumor activity in vitro and in vivo of G C V in tumor 
cells engineered to express HSV-TK (Wu ef al, 1994; Eastham 
ef al, 1996; Kaneko ef al, 1996; Vincent ef al, 1996). How-
ever, few reports describe the biochemical mechanism by which 
G C V elicits potent antitumor effects. In this study, we have 
evaluated the metabolism of G C V and its mechanism of cyto-
toxic action in both primary (HT-29) and metastatic (SW620) 
human colon carcinoma cell lines. Our results demonstrate that 
G C V induced a multilog cell kill in both colon cancer cell lines 
expressing HSV-TK. Furthermore, both cell lines exhibited sub-
stantial killing of bystander cells cocultured with HSV-TK-ex-
pressing cells, even in the absence of high levels of GJIC. W e 
investigated several possible explanations for the increased 
G C V cytotoxicity in SW620 cells, including differences in (1) 
G C V triphosphate accumulation, (2) G C V triphosphate reten-
tion, (3) incorporation of G C V into DNA, and (4) bystander 
killing. 
Our group has previously demonstrated that increased ex-
pression of HSV-TK through transduction with increasing 
amounts of adenovirus resulted in greater cytotoxicity in cul-
tured rat glioma cells (Shewach et al, 1994b). However, these 
results were complicated by toxicity from the adenovims vec-
tor alone. Here we have transduced two colon carcinoma cell 
lines with a retrovims vector encoding the c D N A for HSV-TK 
and developed from each parental cell type more than 10 clonal 
sublines that stably expressed the viral kinase. This system al-
lowed us to determine the effect of increasing HSV-TK ex-
pression on G C V sensitivity without the complication of ade-
novims toxicity. The results demonstrated that these sublines 
varied in their level of expression of HSV-TK, which resulted 
in as much as a 10-fold difference in sensitivity to GCV. Over-
all, the HT-29 sublines were less sensitive than the SW620 cells 
to GCV. However, G C V was highly cytotoxic to both cell lines, 
in which a concentration of 10 /xW effected more than a 2- to 
3-log decrease in cell survival in the HT-29 and SW620 cell 
lines, respectively, following a 24-hr incubation. 
As hypothesized, greater sensitivity to G C V was associated 
with higher levels of G C V nucleotides and incorporation into 
DNA. However, an unexpected result from these studies was 
that the level of G C V triphosphate that accumulated under con-







Table 2. Transfer of [̂ H] G C V Nucleotides Between 
HSV-TK-Expressing and Bystander Cultures" 
[^HjGCV triphosphate (pmol/10^ cells) 
High density Low density 
Total Bystander Total Bystander 
3.10 ± 0.59 
7.41 ± 0.35 
15.37 ± 0.69 
21.01 ± 1.90 
Not det. 
3.39 ± 0.55 
9.27 ± 0.94 
14.27 ± 0.73 
n.d. 
6.72 ± 1.92 
10.23 ± 2.26 
14.68 ± 1.07 
n.d. 
0.55 ± 0.07 
1.04 ± 0.11 
3.97 ± 0.49 
='SW620 cocultures (50:50) of HSV-TK- and pHook-expressing clones were incubated with 
1 /xM G C V (containing approximately 10% [^HIGCV) for the indicated times Bystander cells 
physically separated from HSV-TK-expressing cells with a magnet. Values represent the 
± S E M from two separate experiments. 
Abbreviations: Not det., not detectable; n.d., not detennined. 
were 
mean 
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was relatively low compared with levels of other antimetabo-
lites in these cell types (Shewach ef al, 1994a). As illustrated 
in Fig. 4. accumulation of less than 20 pmol of G C V triphos-
phate per 10* cells was sufficient to effect more than a 3-log de-
crease in cell survival. Thus, G C V ti-iphosphate induced high 
cytotoxicity at intracellular concenttations that were compara-
ble to endogenous deoxynucleotides in the colon carcinoma cell 
lines. In comparison, the antitumor nucleoside analog difluo-
rodeoxycytidine, which also interferes with D N A synthesis as a 
niphosphate, induced only a 1.5-log cell kill in HT-29 cells at 
nucleotide concentrations more than 100 times higher than those 
of G C V (Shewach er al, 1994a). Furthermore, differences of 
approximately 2-fold in G C V triphosphate levels and incorpo-
ration into D N A corresponded to a 10-fold difference in cyto-
toxicity. These results demonstrate that G C V triphosphate is a 
highly potent cytotoxic nucleotide in these colon carcinoma cell 
lines. In our experience with nucleoside analogs that interfere 
with D N A synthesis, this level of cytotoxicity from a nucleotide 
analog is highly unusual, and the mechanism by which G C V in-
teracts so potently with D N A synthesis merits investigation. 
W h e n comparing the sublines of HT-29 and S W 6 2 0 cells, 
increased sensitivity to G C V corresponded to higher levels of 
G C V triphosphate and incorporation into D N A . However, the 
more sensitive HT-29 clone 8 accumulated higher levels of 
G C V triphosphate after 12 hr of drug exposure and was 10-fold 
less sensitive to G C V compared with the more sensitive S W 6 2 0 
clone 3. In addition, retention of G C V triphosphate was slightly 
longer for the less sensitive HT-29 sublines. These apparent 
contradictions may be understood by evaluation of the amount 
of G C V monophosphate in D N A . In a comparison of the four 
clonal lines, greater sensitivity to G C V corresponded to higher 
levels of G C V monophosphate incorporated into D N A (Fig. 6). 
Taken together, these data suggest that incorporation of G C V 
monophosphate into D N A is the factor most predictive of cy-
totoxicity, and that relatively modest increments in D N A in-
corporation result in larger differences in cell survival. 
The data demonstrated that, for all four clonal lines, G C V 
monophosphate was well retained once incorporated into D N A . 
These data are consistent with reports on the stability of G C V 
monophosphate in D N A and on the difficulty in excising it 
(Reardon, 1989; Marshalko et al, 1995). Interestingly, the 
amount of G C V nucleotide in D N A increased for at least the 
first 8 hr following drug washout (Fig. 7), despite the fact that 
the precursor, G C V triphosphate, was decreasing with a half-
life between 3 and 5 hr. These data combined with the obser-
vation that at least 8 % of the G C V nucleotide pool appeared in 
D N A suggest that G C V triphosphate is readily incorporated into 
D N A . This is consistent with reports of low K ^ values for G C V 
triphosphate with mammalian D N A polymerases (Reid et al, 
1988; Reardon, 1989; Ilsley et al, 1995). 
The ability of G C V to kill neighboring cells that do not ex-
press H S V - T K is an important feature of antitumor activity in 
vivo. Here we have demonstrated that bystander killing is de-
pendent on the level of H S V - T K expression, the number of cells 
expressing the viral kinase, and the cell density in both the H T -
29 and S W 6 2 0 cell lines. Paralleling the results in populations 
of cells all of which express H S V - T K , the S W 6 2 0 bystander 
cells were more sensitive to killing compared with HT-29 by-
stander cells when cocultured with HSV-TK-expressing cells. 
Other groups have suggested that bystander killing with G C V 
is mediated by the transfer of G C V nucleotides from HSV-TK-
expressing to nonexpressing cells. Bi and Stambrook initially 
demonsttated the presence of radioactivity in bystander cells 
cocultured with HSV-TK-expressing cells and tritiated G C V , 
although there was no positive identification of the chemical 
nature of the radioactive material retained in bystander cells (Bi 
et al, 1993). Another group demonstrated the transfer of dye 
between cells in coculture, suggesting that soluble metabolites 
such as G C V nucleotides could also be transferred in this man-
ner (Freeman er al, 1993). One report identified transfer of 
phosphorylated G C V in cocultures of HSV-TK-expressing hu-
man and wild-type rodent cell lines (Ishii-Morita et al, 1997). 
Similar to the results presented here, low levels of G C V metabo-
lites were observed in both HSV-TK-expressing and wild-type 
bystander cells. However, these studies were limited to a sin-
gle 24-hr time point, using one concentration of G C V with equal 
amounts of HSV-TK-expressing and xenogeneic bystander 
cells. In addition, the authors identified both bystander-sensi-
tive and -resistant tumor cells and suggested metabolic coop-
eration as a mechanism of transfer but did not examine the level 
of GJIC in these cell lines. Here we have performed a more ex-
tensive study of transfer of phosphorylated G C V between HSV-
T K and bystander cells derived from the same parental line. 
Utilizing the pHook methodology, we have quantitated the 
transfer of G C V nucleotide into the bystander cells in the 
S W 6 2 0 cell line. This transfer occurred within 4 hr, increasing 
with the length of incubation and the density of the cell culture. 
Although we could not produce sufficient pHook expression in 
HT-29 cells to isolate the bystander cells from coculture and 
analyze nucleotide pools, dilution studies using cocultures of 
HT-29 cells expressing H S V - T K and LacZ bystander cells sug-
gest that a similar transfer of G C V nucleotides occurs in these 
cells as well. Furthermore, these studies demonstrate that this 
transfer can occur in a cell line with minimal gap junctional in-
tercellular communication. 
T w o theories have been reported to explain the hypothesized 
transfer of G C V nucleotides to neighboring non-HSV-TK-ex-
pressing tumor cells in vitro following G C V treatment. One 
proposed mechanism hypothesizes that HSV-TK-expressing 
cells undergoing apoptosis develop apoptotic vesicles that may 
contain G C V nucleotides, which are subsequently phagocy-
tosed by non-HSV-TK-expressing cells (Freeman et al, 1993; 
Samejima and Memelo, 1995). W e do not believe this to be a 
prominent mechanism in HT-29 and S W 6 2 0 cells because w e 
were unable to identify apoptotic vesicles visually during the 
course of our experiments. Furthermore, ttansfer of G C V was 
demonsttated to occur within 4 hr after G C V addition to the 
coculture, which is sooner than apoptosis would likely occur in 
competent cell types. 
A second theory suggests that the bystander effect is medi-
ated by the transfer of G C V nucleotides through gap junctional 
channels (Bi er al, 1993; Pitts, 1994). Gap junctions are plasma 
membrane channels that link adjacent cells and permit the pas-
sage of small (<1000 Da) molecules (reviewed in Ruch, 1994; 
Yeager and Nicholson, 1996). These channels are formed by 
two connecting hemichannels (cotmexons), one from each 
neighboring cell, that are composed themselves of six protein 
subunits (connexins, Cx). Several studies have demonsttated a 
sttong correlation between bystander killing and the level of 
GJIC (Pick et al, 1995; Mesnil ef al, 1996). Indeed, the by-
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stander killing in the HT-29 cell line may be mediated by the 
relatively high level of GJIC that we measured. Unexpectedly, 
the S W 6 2 0 cell line exhibited superior bystander killing despite 
a low level of GJIC ( < 3 % ) . While it is still possible that the 
low level of GJIC in this cell line is completely responsible for 
the ttansfer of cytotoxic G C V nucleotides, it appears unlikely 
given the rapid rate of ttansfer of these metabolites into neigh-
boring cells. Other investigators have also reported that S W 6 2 0 
cells are a poorly communicating cell line although they ex-
press connexin 32 (Cx32) m R N A and protein (Mesnil et al, 
1993). W e observed that our S W 6 2 0 and HT-29 clones ex-
pressed Cx32 m R N A at similar levels, but that the localization 
of the protein was different between the cell lines. Immunoflu-
orescence staining indicated that Cx32 was spread diffusely 
over the surface of S W 6 2 0 cells whereas the protein was more 
localized in discrete plaques between adjacent HT-29 cells (data 
not shown). This suggests that Cx32 is expressed in S W 6 2 0 
cells but does not readily form gap junctional plaques and func-
tional intercellular channels, resulting in low GJIC. 
In view of the absence of apoptotic vesicle formation and 
low GJIC, the mechanism that allows the passage of phospho-
rylated G C V from HSV-TK-expressing to nonexpressing 
S W 6 2 0 cells is not clear. With 3 % or fewer of the S W 6 2 0 cells 
able to ttansfer Lucifer Yellow dye to neighboring cells, it 
seems possible but not probable that this accounts for G C V nu-
cleotide transfer. In particular, the fact that the S W 6 2 0 cells 
transferred at least as high a percentage of G C V nucleotides as 
the HT-29 cells, in which 10 times as many cells exhibited 
GJIC, renders it unlikely that the low GJIC in S W 6 2 0 cells can 
account fully for G C V nucleotide transfer. One report suggested 
that rat Novikoff hepatoma cells, which express connexin43 
(Cx43), were able to take up membrane-impermeable dye from 
the culture medium through connexon hemichannels that did 
not align with hemichannels in neighboring cells to form func-
tional GJIC (Li et al, 1996). If the Cx32 protein detected in 
S W 6 2 0 cells represents functional hemichannels, this would be 
a potential mechanism for uptake of G C V nucleotides from the 
extracellular environment. W e and others have demonstrated 
the excretion of low amounts of endogenous nucleotides from 
intact cells, and it is possible that such excretion combined with 
a mechanism for uptake accounts for the transfer of G C V nu-
cleotides between neighboring cells (Dubyak and El-Montas-
sim, 1993; Palmer et al, 1996). Such a mechanism for nu-
cleotide transfer would depend on the proximity of neighboring 
cells, as reported here, since extracellular nucleotides would be 
rapidly diluted in the medium or degraded by enzymes in s e m m 
if the distance they had to traverse was too great. Further study 
is necessary to determine the exact mechanism for G C V nu-
cleotide transfer in S W 6 2 0 cells. 
While there are several studies demonstrating the relevance 
of GJIC for bystander killing with HSV-TK/GCV, the studies 
presented here in S W 6 2 0 cells provide sttong evidence for the 
existence of a novel mechanism. Moreover, this bystander 
killing is mediated by nucleotide transfer. Depending on the ex-
act mechanism responsible for this transfer, it is possible that 
it also contributes to bystander killing in cells that exhibit high 
levels of GJIC. Considering the importance of bystander killing 
in antitumor therapy with H S V - T K / G C V in vivo, complete 
identification and characterization of the process by which 
S W 6 2 0 cells transfer G C V nucleotides is warranted. 
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